MDxHealth SA (MDXH) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day and welcome to the MDX Health fourth quarter and full year 2025 earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on a touch-tone phone. To withdraw your question, please press star then two. Please note that this event is being recorded. I would now like to turn the conference over to John Francis with LifeSci Advisors. Please go ahead. Before we begin, I'd like to remind everyone that the company will make forward-looking statements during today's call. Whether in prepared remarks or during the Q&A session, these forward-looking statements are subject to inherent risks and uncertainties. These risks and uncertainties are detailed in the risk factor section of the company's filings with the Securities and Exchange Commission, specifically in the company's annual report on Form 20F. I'll now turn the call over to Michael McGarrity, Chief Executive Officer. Thanks, John. And thank you all for joining us for our fourth quarter and full year 2025 Earnings Conference call for MDX Health. With me today is Ron Kalfas, who has returned as our Interim Chief Financial Officer. We've been very consistent in our message and mission that MDX Health is driven by three core operating principles. focus, execution, and growth. We believe that our strong results throughout 2025 demonstrate this commitment, and that our guidance for 2026 will require that same commitment. We are very confident in our ability to deliver. Over the past few years, operating discipline, commercial execution, and an aggressive growth strategy has po...